Moffitt Cancer Center Researchers Validate New Staging Classifications for Neuroendocrine Pancreatic Tumor Surgery Response

Monday, April 02, 2012

Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery.